‘Rplate’™ – rapid antibiotic susceptibility test

A rapid, low cost, antibiotic susceptibility test for urinary tract infections

• Rapid time to result (TTR) (< 30m)
• Mass-manufacturable, platform
• High sensitivity and repeatability
• Affordable price

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics

Microorganisms:
  • Bacteria
  • Fungi

Application:
  • Human
  • Veterinary

Development stage:
  • Development

Organization:
  • Company

Partnering:
  • Co-develop

Funding organisation:
  • OTHER / NA

Infectious disease area:
  • UTI
  • BSI
  • RTI

Geographic origin:
  • Eurasia


Global commercilisation partner – large/medium-sized IVD company to negotiate a deal where our partner would be responsible for sales, marketing, technical support and regulatory approval in the agreed territory, whether global or regional

Spinout company from the University of Strathclyde, Glasgow, UK

In time, we will expand the product platform to tackle not only UTIs, but other infections including systemic sepsis, respiratory tract infections, meningitis and systemic fungal infections etc


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!